Differentiated control of deranged nitric oxide metabolism: a therapeutic option in sepsis?
Open Access
- 29 May 2013
- journal article
- review article
- Published by Springer Nature in Critical Care
- Vol. 17 (3) , 311-9
Abstract
Derangement of nitric oxide (NO) metabolism represents one of the key mechanisms contributing to macro- and microcirculatory failure in sepsis. Sepsis-related therapy combining fluid resuscitation with administration of vasopressor and inotropic agents, however, does not guarantee correction of maldistributed nutritive perfusion between and within organs. Therefore, the differentiated and selective pharmacologic modulation of NO-mediated vascular function could play a useful role in hemodynamic management of patients with sepsis. This viewpoint carefully evaluates the potential role of intentionally using partially opposing effects of NO donors and NO synthase inhibitors to complement current therapy of hemodynamic stabilization in patients with sepsis.Keywords
This publication has 47 references indexed in Scilit:
- Quantitative assessment of the microcirculation in healthy volunteers and in patients with septic shock*Critical Care Medicine, 2012
- Asymmetric Dimethylarginine, Endothelial Nitric Oxide Bioavailability and Mortality in SepsisPLOS ONE, 2011
- Acute Endotoxemia Inhibits Microvascular Nitric Oxide-Dependent Vasodilation in HumansShock, 2011
- Time course of nitric oxide synthases, nitrosative stress, and poly(ADP ribosylation) in an ovine sepsis modelCritical Care, 2010
- Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: A double-blind randomized placebo controlled trialCritical Care Medicine, 2010
- ROLE OF RETINOID-X RECEPTOR-α IN THE SUPPRESSION OF RAT BILE ACID COENZYME A-AMINO ACID N-ACYLTRANSFERASE IN LIVER DURING SEPSISShock, 2007
- EFFECTS OF COMBINING INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITOR AND RADICAL SCAVENGER DURING PORCINE BACTEREMIAShock, 2007
- Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*Critical Care Medicine, 2004
- Albumin resuscitation increases cardiomyocyte contractility and decreases nitric oxide synthase II expression in rat endotoxemia*Critical Care Medicine, 2003
- Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidaseFEBS Letters, 1994